In the recent case Illumina, Inc. v. Ariosa Diagnostics, Inc., the Federal Circuit found that claims directed to methods of preparing DNA samples for analysis satisfy the patent eligibility requirement of 35 USC § 101. The patents at issue covered subject matter directed to distinguish and separate the little amount of fetal DNA from the […]